'Forced treatment interruptions' and risk of HIV resistance in countries adopting law enforcement against marginalized populations [3]

AIDS

Volumn 21, Issue 8, 2007, Pages 1062-1063

  Carrieri, Maria Patrizia ^a   Spire, Bruno ^a  

^a OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE;

DETENTION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG USE; EASTERN EUROPE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS ABUSE; INFECTION RISK; LAW ENFORCEMENT; LETTER; PRIORITY JOURNAL; PRISON; PROSTITUTION; PSYCHOSOCIAL CARE; PUBLIC HEALTH; REHABILITATION CENTER; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; HEALTH CARE RATIONING; HIV INFECTIONS; HUMANS; POLICE; SUBSTANCE-RELATED DISORDERS;

EID: 34247607169     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328012b5e8     Document Type: Letter

References (10)

1. Scaling up provision of antiretrovirals to injecting drug users and non injecting drug users in Asia. Melbourne: Asian Harm Reduction Network; 2004.
2. Carrieri MP, Moatti JP, Vlahov D, Obadia Y, Reynaud-Maurupt C, Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Commun Health 1999; 53:4-8.
3. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002; 54:1481-1496.
4. Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin Infect Dis 2004; 38 (Suppl. 5):S409-S413.
5. Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS 2000; 14:151-155.
6. Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther 2004; 9:713-719.
7. Palepu A, Tyndall MW, Li K, Yip B, O'Shaughnessy MV, Schechter MT, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health 2003; 80:667-675.
8. Friedman SR, Cooper HL, Tempalski B, Keem M, Friedman R, Flom PL, Des Jarlais DC. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006; 20:93-99.
9. Hammett TM, Bartlett NA, Chen Y, Ngu D, Phuong NM, Tho NH, et al. Law enforcement influences on HIV prevention for injection drug users: observation from a cross border project in China and Vietnam. Int J Drug Policy 2005; 16:235-245.
10. Human Rights Watch. Fanning the flames: how human rights abuses are fueling the AIDS epidemic in Kazakhstan. Vol. 15, No. 4. New York; 2003.